Cambridge Investment Research Advisors
OGN icon

Cambridge Investment Research Advisors’s Organon & Co OGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
13,016
-2,763
-18% -$33K ﹤0.01% 3863
2026
Q1 		$95K Sell
15,779
-5,794
-27% -$43.6K ﹤0.01% 3800
2025
Q4 		$155K Sell
21,573
-12,771
-37% -$101K ﹤0.01% 3626
2025
Q3 		$367K Sell
34,344
-9,553
-22% -$93.8K ﹤0.01% 2950
2025
Q2 		$425K Buy
43,897
+752
+2% +$7.76K ﹤0.01% 2684
2025
Q1 		$642K Buy
43,145
+243
+0.6% +$3.74K ﹤0.01% 2209
2024
Q4 		$640K Sell
42,902
-8,767
-17% -$143K ﹤0.01% 2227
2024
Q3 		$988K Buy
51,669
+1,705
+3% +$35.3K ﹤0.01% 1862
2024
Q2 		$1.03M Buy
49,964
+11,254
+29% +$224K ﹤0.01% 1750
2024
Q1 		$728K Buy
38,710
+18,733
+94% +$321K ﹤0.01% 1962
2023
Q4 		$288K Sell
19,977
-4,182
-17% -$56.9K ﹤0.01% 2624
2023
Q3 		$419K Buy
24,159
+1,838
+8% +$38.3K ﹤0.01% 2233
2023
Q2 		$465K Sell
22,321
-5,767
-21% -$125K ﹤0.01% 2195
2023
Q1 		$661K Sell
28,088
-326
-1% -$8.75K ﹤0.01% 1892
2022
Q4 		$794K Sell
28,414
-3,526
-11% -$90.2K ﹤0.01% 1668
2022
Q3 		$747K Buy
31,940
+155
+0.5% +$4.68K ﹤0.01% 1673
2022
Q2 		$1.07M Sell
31,785
-609
-2% -$21.3K 0.01% 1430
2022
Q1 		$1.13M Sell
32,394
-2,003
-6% -$68.5K 0.01% 1485
2021
Q4 		$1.05M Sell
34,397
-6,320
-16% -$206K ﹤0.01% 1552
2021
Q3 		$1.33M Buy
40,717
+2,219
+6% +$71K 0.01% 1327
2021
Q2 		$1.17M Buy
+38,498
New +$1.27M 0.01% 1423

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Cambridge Investment Research Advisors's OGN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Organon & Co (OGN) stake by 18% in Q2 2026, selling an estimated $33K and leaving 13,016 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3863.

Cambridge Investment Research Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.33M in Q3 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Cambridge Investment Research Advisors held 13,016 shares of Organon & Co worth $176K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,763 Organon & Co shares in Q2 2026, an estimated $33K.
  • Organon & Co made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3863 holding.
  • Cambridge Investment Research Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Cambridge Investment Research Advisors's Organon & Co position peaked at $1.33M in Q3 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.